AstraZeneca's Farixga Gets US Fast Track Designation In Kidney Disease
(Alliance News) - AstraZeneca PLC on Tuesday said the US has granted fast track designation for the development of Farixga as a treatment for renal failure in chronic kidney disease.The US Read More